SEALEO
Company

SEALEO

Biotechnology Research Space, United Kingdom 6 employees
Employees
6
Contacts
2
Emails
2

SEALEO Overview

Headquarters
Space, United Kingdom
Industry
Biotechnology Research
Employees
6
Founded
2024
Funding
25.3K
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords

About SEALEO

Sealeo is on a mission to eliminate waste in the pharmaceutical industry by revolutionizing last-mile vaccine delivery. Currently, 50% of vaccines are wasted globally, releasing 2.5 million tonnes of CO2 and claiming the lives of 2-3 million children annually. The main reason for this wastage is inadequate packaging solutions that fail to address the unique challenges of last-mile delivery. On top of this, current solutions continue to rely on materials such as polystyrene and synthetic coolants, which contribute 10 million tons of CO2 annually. Sealeo offers a novel packaging material designed to keep vaccines cold passively, effectively, and affordably. Our fully biodegradable, cost-effective, and lightweight material offers unparalleled adaptability. Its flexibility and moldability allow it to be custom-shaped to the exact dimensions of the medicine being transported, boosting efficiency in last-mile delivery and significantly reducing greenhouse gas emissions.

SEALEO Contact Details

People in AeroLeads
4
With contact data
2
Email contacts
2
50.0% coverage

SEALEO Org Chart

Sample employees and titles
Name Title Contact
Marta Kask Software Developer at Swiss Re
View
Nadia Havard Senior International Surety Underwriter
Email
Emanuele Griccioli Co-founder @Sealeo - Raeng 1851 Royal Commission Enterprise Fellow
View
Diana Epel Co-founder @Sealeo ║ Ma/msc Innovation Design Engineering at Royal College of Art & Imperial College
Email

Employees by Management Level

Executive 2 profiles
Senior / Lead 1 profile
Individual contributor 1 profile

SEALEO Tech Stack

Engineering 2 profiles

Compare Similar Companies to SEALEO